chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash on the wrist and on both arms  bumps that are itchy; faster heartbeat that usual; Soreness on the shoulder; Soreness underneath the arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Rash on the wrist and on both arms  bumps that are itchy), TACHYCARDIA (faster heartbeat that usual), ARTHRALGIA (Soreness on the shoulder) and LIMB DISCOMFORT (Soreness underneath the arm) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced RASH PRURITIC (Rash on the wrist and on both arms  bumps that are itchy), TACHYCARDIA (faster heartbeat that usual), ARTHRALGIA (Soreness on the shoulder) and LIMB DISCOMFORT (Soreness underneath the arm). At the time of the report, RASH PRURITIC (Rash on the wrist and on both arms  bumps that are itchy), TACHYCARDIA (faster heartbeat that usual), ARTHRALGIA (Soreness on the shoulder) and LIMB DISCOMFORT (Soreness underneath the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concominant medications were not reported.  Treatment information was not provided.
bubbles in her arms, kind of looked a smidgeon like poison ivy; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 for COVID-19 immunization. The patient experienced bubbles in her arms, kind of looked a smidgeon like poison ivy on an unspecified date. The patient was hospitalized for the event for 30 days (patient was in the hospital for about a month). Reporter stated she is calling regarding the Pfizer Covid 19 second dose, the vaccine. Reporter was reporting her own experience with the Pfizer Covid 19 vaccine, she mentioned that she did some research online and read about 2 people's reactions. When she googled the second dose of Pfizer and reactions to the Pfizer vaccine, she typed in the words burning in arms, legs, feet and hands. She pulled up one article from the newspaper of a woman who was in the hospital about a month. In the picture, it looked like bubbles in her arms, kind of looked a smidgeon like poison ivy. The other was a man, and she does not know the location. It was in the newspaper that he had a rash. It might have been reversed but she does not remember their names. The other one had a rash. Outcome of the event was unknown.  Information about Lot/batch number has been requested.
stomachache; nausea; constipation; This is a spontaneous report from a contactable consumer (patient).   A 71-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date as 2nd single dose for covid-19 immunisation. The patient medical history and the patient's concomitant medications were not reported. The patient received the first dose of BNT162B2 on unknown date. A whole week after the second dose the patient experienced stomachache, nausea and constipation, all non-serious on an unspecified date with outcome of unknown.    Information on the lot/batch number has been requested.
COULD NOT SLEEP; PRETTY ACHY; LETHARGIC; CHILLS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced could not sleep, pretty achy, lethargic, and chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from could not sleep, pretty achy, lethargic, and chills. This report was non-serious.
Patient stated she had numbness in face, neck and arm after receiving her flu shot that lasted 24 hours and then resolved.
p/vax pt devel rash described as diffuse over body & was noted to be blotchy;rash noted to be raised in some areas & would become raised when touched;pt had severe itching on scalp, hands & feet;also suffered some bronchospasm;urticarial;
PT WAS VERY NERVOUS AND AS SOON AS I FINISH ADMINISTERING VACCINE SHE TOLD MOM NOT FEELING GOOD TURN PALE, AND MOM RESTED HER ON FLOOR WITH HER .
Patient is only 17 and received a dose of Moderna, which is currently only approved for patients 18 years of age and older.
I discovered a lump in my left breast, but I am unsure if it is related to the vaccine.
I had an adverse reaction to the Gardasil vaccination when I received the second and third vaccines in the series. My hands and feet tingled and swelled, building up slowly over the course of several days until I woke up one morning and was unable to close my hand because it was so swollen, and it hurt to walk on my feet. I painstakingly made it to the clinic and was given numerous medications and a large shot of Benadryl. It was not until I started to feel the tingling feeling again a day or so after my third vaccination that the connection was made between the vaccine and my reaction.
Patient Received vaccines as indicated below. The Follow Evening mom Report left arm (Deltoid area Red 3 in x 3.5 in, slightly Raised, warm to touch and puritis. To ER per father. Recommended Tylenol and Ice mom complied and Began to resolve by Sunday Evening
Patient with low grade fever (tmax 99.6), body aches, and pain at injection site.  Taking motrin with some relief.
Likely myocarditis s/p 2nd dose of Pfizer COVID vaccine.  From hospital note: Pt was in his usual state of health when he received the second dose of Pfizer mRNA Covid vaccine on 6/3.  On 6/6, he developed substernal nonradiating chest pain, as well as low-grade temperature to 99.6.  Pain persisted, so he presented to the emergency department on 6/6.  He did not have respiratory symptoms, nausea, vomiting, diarrhea, conjunctival injection, new rashes.  In the emergency department he was afebrile with normal vital signs.  Laboratory evaluation in the ED demonstrated WBC 7.45 (N 64, L 19), Hb 14.5, PLT 191, ESR 10, CRP 0.69, AST 46, ALT 14.  BNP 23.  He was noted to have a troponin leak (troponin T 0.55).  Covid PCR and antibody testing were negative.  An EKG demonstrated early repolarization but was otherwise normal.  An echo demonstrated mildly dilated LV with good systolic function. Pt was admitted to the cardiology service for further evaluation and management of myocarditis.  Following admission he remained afebrile with stable vital signs, but continued to have troponin leak.  He was initiated on methylprednisolone 30 mg IV every 12 hours, and IVIG 2g/kg x1.    Pt is a 15 year old with what appears to be myocarditis after the SARS_CoV2, with significant troponin elevation, coming down, chest pain, improved with IVIG and steroids, and ibuprofen prn. Plan for cMRI to look for late gadolinium enhancement to guide course of therapy.
Influenza 6-35 months 0.25 cc was ordered by physician. Influenza 0.5cc was given by nurse.
Information has been received from a registered nurse concerning 6 patients who between 09-MAR-2010 and 18-MAR-2010 received a 0.5 ml IM dose of PNEUMOVAX 23 (lot# 664476/1190Y).  Between 09-MAR-2010 and 18-MAR-2010, 24 hours after vaccination with PNEUMOVAX 23, the patients developed cellulitis reaction on their arms.  The patients sought unspecified medical attention.  At the time of the report, the outcome of the patient was unknown.  A standard lot check investigation has been finalized.  All in-process quality checks for the lot number 664476/1190Y were satisfactory.  The lot met the requirements of the Research Center and was released.  The nurse contacted during telephone follow-up could not supply the following information:  patient names, dates of birth, dates of vaccination, dates of events and recovery status.  Follow-up information has been received from a registered nurse concerning a 52 year old male with hypertension and no pre-existing allergies, birth defect, medical conditions who on 15-MAR-2010 at 11:00 AM was vaccinated in left arm with a dose of PNEUMOVAX 23 (LOT # 664476/1190Y).  On 16-MAR-2010 at 14:10 the patient experienced left arm swelling and was diagnosed with cellulitis.  The patient was given clindamycin for 7 days.  Subsequently, on 19-MAR-2010 the patient recovered.  No further information is available at this time of reporting.  This is one of several reports received from the same source.  Additional information has been requested.
I had severe pain under my arms and in my chest area.  I have severe swelling under both arms, especially my left arm.  (Lymphedema).  I had severe fatigue, nausea, headache, fever, and aches.
headache; Pain; Itching at Injection Site; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 20Feb2021 17:30 (Batch/Lot number was not reported) as dose 2, single (age at vaccination 68-year-old) for covid-19 immunisation. Medical history included diabetes mellitus and High cholesterol from an unknown date and unknown if ongoing. Concomitant medication(s) included metformin (METFORMIN) taken for an unspecified indication, start and stop date were not reported. Historical vaccine information included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection) 1st dose on 30Jan2021, administration site (Left arm), administered at 05:45 PM (age at vaccination 68-year-old) for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. No known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was not pregnant at the time of vaccination. On 21Feb2021 06:00, the patient experienced headache, pain, itching at injection site (vaccination site pruritus). Therapeutic measures were taken as a result of events includes TYLENOL. The outcome for all events was recovering.  Follow-up attempts completed. No further information expected.
A report was received from a health care professional on 12/8/03 concerning 5 children of unspecified sex and aged between 8 months and 3 years of age who inadvertently received Fluvirin on 12/6/03. On 12/6/03, five children inadvertently received Fluvirin. At the time of the report, no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 3/8/04: Follow up information received from a health care professional indicated that a 2.5 year old female vaccinee inadvertently received Fluvirin on 12/6/03. No adverse events have been reported to date. No follow up pending. All information received.
Information has been received from a nurse referring to unspecified amount of patients of unknown age and gender. The patients' medical history, concomitant therapy and drug reactions were not reported. On unspecified dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 (lot # M011117, expiration date 07-DEC-2017, dose and route were not provided), which were exposed to 50 Fahrenheit (F) for 40 minutes. Previous temperature excursion: 50.2 for 1 hour and 10 minutes. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
developed cold like symptoms...sinus congestion, mild H/A, non-prod cough, sore throat, lethargy
Per vaccinator, while adminstering vaccination the syringe separated from the needle and the vaccine sprayed out. A replacement dose was given.   Syringe/needle was Haiou brand.
Patient received first shingrix shot on 6/7/22. On 6/11/22 she called the pharmacy and reported redness and warmth to the vaccination site presuming possible infection or reaction to vaccination. Patient went to patient first and received cephalexin for treatment. She was not upset and understood the situation.
Case previously recorded as MA2009-4428.  We received the following information via agency from a nurse on 16 NOV 2009:  A 35-year-old female patient was vaccinated i.m. with FLUVIRIN (batch number 102042P1A) on 16 NOV 2009.  During administration half the dose dripped from the needle and half the dose was wasted.  The dose was drawn from a multi dosage vial and the reporter stated that the needle and the syringe were not well connected.  Underdose of S-OIV FLUVIRIN is unexpected.  No change in benefit-risk-ratio.  No measures necessary.  Agency ref. no.: NA09-008257.
Information has been received from a physician concerning a 67 year old female who on 17-APR-2007 was vaccinated with a dose of Zostavax. On 17-APR-2007 the patient experienced "injection site reaction" which included redness, lump, warmness and itching at injection site. Patient was treated with Keflex. The patient recovered on the same day. A product quality complaint was not involved. Additional information has been requested.
Received Tdap and Varicella and Menactra on 8/14.  Started with soreness in Left shoulder soon after.  Soreness and pain with movement continued and I saw her on 9/16.  She was very uncomfortable with abduction and anterior rotation of L shoulder
Developed body aches and joint pain 12/4/2021 around 6 pm, no fever presented at this time. Left arm was slightly sore with no redness or swelling. On 12/5/2021 at 12:45 am, I woke up with a fever of 101, body aches, joint pain, chills, headache and soreness in left arm. Took ibuprofen to help relieve symptoms.  Continued to take ibuprofen as needed. On 12/5/2021, I was very tired, continued having body aches, joint pain, chills and headache. My arm also began to turn red and swell. Symptoms were slightly relieved with ibuprofen, however, they would return quickly once the medication wore off. On 12/6/2021 around 4 am, I awoke with a fever of 102. This was the highest temperature that I had. I continued to use ibuprofen to relieve symptoms. When I awoke on 12/7/2021 and still felt miserable, I contacted my Doctor's office. I was advised that I should come in to be seen. Dr. is the doctor who treated me. He started me on an antibiotic for my arm as it was red, hot to touch and swollen. He diagnosed me with having a arthus reaction to the Covid-19 vaccine.
Warm to touch at the injection site; A little black and blue; Itching; Arm was sore; Large area that's hot pink; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm was sore), VACCINATION SITE BRUISING (A little black and blue), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE ERYTHEMA (Large area that's hot pink) and VACCINATION SITE WARMTH (Warm to touch at the injection site) in a 95-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm was sore), VACCINATION SITE BRUISING (A little black and blue), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE ERYTHEMA (Large area that's hot pink) and VACCINATION SITE WARMTH (Warm to touch at the injection site). At the time of the report, VACCINATION SITE PAIN (Arm was sore), VACCINATION SITE BRUISING (A little black and blue), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE ERYTHEMA (Large area that's hot pink) and VACCINATION SITE WARMTH (Warm to touch at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
No additional AE; received an expired VAQTA; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. Information about the patient's concurrent conditions or medical history was not reported. Concomitant medications included an influenza vaccine (unspecified).  On 06-NOV-2021, the patient received 1 mL of an expired dose of hepatitis a vaccine, inactivated (VAQTA) (Expired product administered) (lot # T017179, expiration date 26-OCT-2021) for prophylaxis (dose number, route of administration, and anatomical location were not reported). It was reported that the vaccine did not have any temperature excursion. The medical assistant observed the patient, no additional adverse events were reported.
RIGHT HAND SWELLING AND SENSITIVITY TO TOUCH. AS OF TODAY DAUGHTER VERIFIED SWELLING AND SENSITIVITY HAS BEEN RESOLVING BUT STILL BOTHERING PATIENT
woke up after the vaccines with a fever and large and hot bump on her upper right arm. Resolved the next day
Felt hard lump where vaccine was given.  The area was also warm to the touch.  Outside the very red, hard area, was a lighter red area, which seemed to be getting larger.  Some itching.  First used Benadryl.  Then Dr told me to take 20 mg Prednisone for 3 days.  However, when I told my husband he said that was the wrong thing to do, that prednisone can interfere with vaccine.  So, I had already taken it for 2 days, then stopped.  Eventually it got better.
I went to bed with my arm feeling extremely achy. I woke up a few hours later with a terrible stomach ache, the chills (probably had a fever), and redness/slight swelling in the arm where the shot was received. I also felt achy in my back & neck & shoulder.  I took some Tylenol which helped with the aches & fever. It's now noon on 6/19 and I'm still feeling pretty miserable.
Pr received 1st HPV vaccine and eyes rolled back and had syncopal episode lasting < 10 seconds. Mom reports a mild twitch after syncope pallor noted.
Nurse inadvertently administered Tetanus instead of PPD-had 3.7 x 3cm redness and 0.22cm raised center.
ADMINISTRATION OF EXPIRED VACCINE 6 DAYS AFTER EXPIRATION DAY; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A, and expiry: 21-SEP-2021) dose was not reported, administered on 27-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 27-SEP-2021, the patient experienced administration of expired vaccine 6 days after expiration day. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of expired vaccine 6 days after expiration day was not reported. This report was non-serious.
Chills Fever Joint and Muscle Pain Fatigue Injection Site redness and swelling.
Pain (severe) and tenderness at injection site. Arm is swollen and tender from elbow to neck. No yet recovered.
Tingling prickly skin - raised red hives covering torso, legs and upper arms for 3 night in a row  (4th, 5th and 6th day after injection)   No rash at injection site
Information has been received from a physician concerning a 14 year old female with a history of recurrent urticaria who on 02-OCT-2007 was vaccinated with her first dose of Gardasil (lot# 657737/0522U). Within three hours of receiving the dose the patient experienced dizziness, headache and fever. On 03-OCT-2007 the patient experienced nausea, vomiting and abdominal pain. The patient's dizziness, headache, fever, nausea, vomiting and abdominal pain persisted. The patient sought unspecified medical attention by the physician. Concomitant therapy included CLARINEX. Additional information has been requested. This is in follow-up to report (s) previously submitted on 11/14/2007.  Initial and follow-up information has been received from a physician concerning a 14 year old female with no illness at the time of vaccination, a history of recurrent urticaria and drug hypersensitivity to "cydizir", "cyprozil", erythromycin, clavulanete, ceclor and sulfonamide who on 02-OCT-2007 was vaccinated with her first dose of GARDASIL (lot# 657737/0522U) in the lower left arm IM at 10:14 AM.  Concomitant therapy included CLARINEX daily.  On 02-OCT-2007, within three hours of receiving the dose (also reported as 03-OCT-2007).  The patient experienced dizziness, headache and fever.  On 03-OCT-2007 at 10 AM the patient experienced nausea, vomiting and abdomial pain.  The patient's dizziness, headache, fever, nausea, vomiting and abdominal pain persisted.  The patient sought unspecified medical attention by the physician.  Additional informatin is not expected.
1/26/22 pt admitted to hosp with AMS and weakness; planned to dc to SNF on 1/31/22, but was found to be COVID positive; given dexamethasone, remdesivir; O2 supplementation; dc'd to SNF on 2/10/22; back to ED on 3/5/22 with increased confusion and urinary incontinence x 2 days; on baseline of O2 3 LPM via NC; increased O2 to 6 LPM via NC; admitted with acute bilateral pneumonia, acute respiratory failure; given IV fluids and ABX; condition worsened; placed on BiPAP; pt pulling BiPAP off requiring restraints; family made pt a DNR and then transitioed to comfort care; pt expired in the hospital
PT REPORTED OF LOCALIZED REACTION TO INJECTION SITE OF RASH AND ITCHINESS. PT REPORTED THAT REACTION OCCURRED WHILE AT HOME.
pt recvd vax & devel guillain barre synd; URI , viral synd; sequelae bell palsy & extremities weakness; pt hosp 5 wks;
Had chills, muscle aches and fatigue six hours after shot administered on the 14th.  Then was confirmed by CT scan diverticulitis on the 19th.  Prescribed Cipro/Flagyl for meds.  Two and a half days in, fatigue, body sweats, overwhelming radiating heat over entire body and racing heart.  Went back to ER on 22nd.  Did enzyme test to rule out heart attack, switched med regimen to Amoxicillin/Bactrim and took that until 7 days post meds.  No pain from diverticulitis but same symptoms of fatigue, body sweats, overwhelming radiating heat over entire body and racing heart persisted.
Information has been received from a consumer concerning her son, who received the routine vaccines (names and manufacturer unspecified) at five or six months old and subsequently started to deteriorate. Then after the patient's first birthday, in May 2002, he received the first dose of MMR II (Lot number not reported) and right after receiving MMR II the patient completely regressed. The patient lost eye contact, did not complete his words, and lacked in communication and socialization skills and was diagnosed with autism. At the time of the report, the mother stated that her son, now 8 years old, had gotten better due to intervention treatments but he still had some problems. Upon internal review, autism was considered to be an Other Important Medical Event. No further information is available.
Initial itching, then swelling & red rash 5" high & 3" wide at injection area